Search alternatives:
material » materials (Expand Search)
Showing 1,341 - 1,360 results of 2,756 for search 'material dysfunction', query time: 0.11s Refine Results
  1. 1341

    Mechanisms of alleviating sepsis-induced rat lung and kidney damage by inhibiting expression of miRNA-939 by Anwaier Apizi, Jian Li, Yan Li, Zhaoxia Yu, Ruifeng Chai

    Published 2025-06-01
    “…These findings highlight the therapeutic potential of targeting miRNA-939 in the management of sepsis-induced organ dysfunction.…”
    Get full text
    Article
  2. 1342

    Clinical features and mutational frequency of renal cell carcinoma from patients undergoing kidney transplant evaluation by Corbin J. Eule, Junxiao Hu, Kurtis D. Davies, Alkesh Jani, Alkesh Jani, Thomas Pshak, Elaine T. Lam

    Published 2025-05-01
    “…Despite increased understanding of genomic alterations in clear cell and papillary RCC, the most common subtypes, little is known about the effects of renal dysfunction on RCC pathogenesis.Materials and methodsThis retrospective study analyzed electronic medical records and pathology data from adult patients with renal cell carcinoma (RCC) who were evaluated for or received a kidney transplant at a single institution between 1995 and 2021. …”
    Get full text
    Article
  3. 1343

    Renal transplant pathology and factors determining the rate of its progression by Е. S. Stoliarevich, E. T. Egorova, N. P. Mozheiko, D. A. Saydulaev

    Published 2025-03-01
    “…Objective: to evaluate the factors influencing the rate of nephropathy progression depending on the nature of dysfunction. Materials and methods. The study included 189 kidney transplant recipients with morphologically verified renal graft dysfunction. …”
    Get full text
    Article
  4. 1344

    Heart transplantation in patients undergoing extracorporeal cardiopulmonary resuscitation in in‑hospital cardiac arrest by V. N. Poptsov, E. A. Spirina, A. K. Solodovnikova, A. S. Epremyan, A. A. Kuznetsova, A. S. Ignatkina, G. B. Glinkin, S. A. Budagaev

    Published 2025-01-01
    “…Five (19.2%) recipients developed severe dysfunction, which required continuation of peripheral VA-ECMO in the postperfusion period. …”
    Get full text
    Article
  5. 1345

    Pulmonary Vascular Thrombosis in COVID-19: Clinical and Morphological Parallels by O. Ya. Porembskaya, V. N. Kravchuk, M. I. Galchenko, R. V. Deev, M. Sh. Chesnokov, A. V. Avanesyan, K. V. Lobastov, S. N. Tsaplin, L. A. Laberko, V. S. Ermakov, O. V. Pashovkina, I. V. Schastlivtsev, S. A. Sayganov

    Published 2022-09-01
    “…The D-dimer level correlates with lung, renal dysfunction, patients' mortality and doesn't show any correlation with ACT and can be accepted as a criterion of lung vessel thrombotic progression.…”
    Get full text
    Article
  6. 1346

    Efficacy and safety of prolonged-release hyaluronic acid derivative vaginal application in the postpartum period: a prospective randomised clinical trial by Claudio Gustavino, Paolo Sala, Nadia Cusini, Brunella Gravina, Cecilia Ronzini, Diletta Marcolin, Valerio Gaetano Vellone, Michele Paudice, Rossella Nappi, Sergio Costantini, Simone Ferrero, Fabio Barra

    Published 2021-01-01
    “…Introduction In puerperium, the hypoestrogenic state induced by delivery and subsequently sustained by lactation may lead to vaginal dryness, burning, and itching sensation, contributing to the onset of sexual dysfunction.Material and methods This was a prospective, randomized, controlled, open-label study (NCT04560283) for evaluating the effects of application of a prolonged-release hyaluronic acid derivative vaginal gel in restoring sexual function during the postpartum period. …”
    Get full text
    Article
  7. 1347

    Preemptive Analgesia with Nonsteroidal Anti-Inflammatory Drugs in the Perioperative Period by M. S. Danilov, I. S. Simutis, D. S. Salygina, E. G. Polovtsev, A. A. Syrovatsky, V. A. Ratnikov, A. A. Bogatikov, A. E. Karelov

    Published 2024-02-01
    “…More rare occurrence of renal dysfunction in Group 1 patients is indicative of lower nephrotoxicity of ibuprofen.…”
    Get full text
    Article
  8. 1348

    Impact on the Quality of Erections after Completing a Low-Intensity Extracorporeal Shock Wave Treatment Cycle on a Group of 710 Patients by Héctor A. Corredor Ayala, José Pablo Saffon Cuartas, Diana Cerquera Cleves

    Published 2017-01-01
    “…The aim of this study is to evaluate the response to low-intensity extracorporeal shock wave therapy in a group of patients with organic vascular erectile dysfunction. Materials and Methods. This is an observational retrospective study. …”
    Get full text
    Article
  9. 1349

    The Triglyceride–Glucose Index, a Marker of Insulin Resistance, Is Associated with the Myocardial Performance Index in Asymptomatic Subjects by Necip Nas, Muzaffer Aslan, Semih Saglik, Hafize Uzun

    Published 2025-05-01
    “…The MPI provides a comprehensive view of the overall efficiency of the heart’s pumping ability, making it a valuable tool for detecting early signs of heart dysfunction, even in the absence of overt symptoms. …”
    Get full text
    Article
  10. 1350

    STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS by E. V. PASHCHENKO, A. I. CHESNIKOVA, V. P. TERENTYEV, V. I. KUDINOV, E. A. DEVETYAROVA

    Published 2018-10-01
    “…This study was designed to determine the structural and functional features of left ventricle in patients with heart failure, coronary heart disease and thyrotoxicosis.Materials and methods. 85 patients aged 58.3±5.6 years were divided into 3 groups: the main one – 25 patients with coronary  heart disease (CHD), chronic heart failure (CHF) II-III functional  classes (FC) and thyrotoxicosis, average age –59.23±3.81; the 1st  comparison group – 30 patients with CHD and CHF FC II-III without  thyroid dysfunction, the average age – 57.6±2.73; the 2nd  comparison group – 30 patients with thyrotoxicosis without  concomitant cardiovascular diseases (CVD), the average age –  45.4±3.51. …”
    Get full text
    Article
  11. 1351
  12. 1352

    Characterization of the gut microbiota and systemic inflammation in HIV-exposed uninfected infants from a resource-limited setting at 6 weeks of age by P. Munjoma, A. Mazhandu, J. Wyss, S. Ulrich Jordi, L. Katsidzira, B. Yilmaz, B. Misselwitz, K. Duri

    Published 2024-11-01
    “…Notably, several significant positive correlations were observed between inflammatory and endothelial dysfunction biomarker levels (p<0.05). However, no significant associations were found between gut microbial taxa relative abundances and plasma inflammatory or endothelial dysfunction biomarker levels. …”
    Get full text
    Article
  13. 1353

    Clinical Outcomes in Diabetic Females Presenting with STEMI: A Cohort Study by Anjana Ajith Beena, Priya Shanmukhan, Veena Felix, Alummoottil George Koshy, Kunjukrishnapilla Sivaprasad

    Published 2025-01-01
    “…Conclusion: Despite a high rate of revascularisation and fewer procedure-related complications, outcomes remain grim, with a higher incidence of heart failure, cardiogenic shock, renal dysfunction and mortality. A worse clinical profile, left ventricular dysfunction and renal dysfunction were significant predictors of mortality.…”
    Get full text
    Article
  14. 1354

    LONG-TERM AND LATE EFFECTS OF CHEMOTHERAPY IN CHILDHOOD ACLEUKEMIA AND THEIR MANAGEMENT SINGLE INSTITUTION OBSERVATIONUTE LYMPHOBLASTIC by Konul Baghirova

    Published 2025-07-01
    “…These adverse effects include cardiotoxicity, secondary malignancies, endocrine dysfunction, and neurological damage. Given the limitations of conventional treatment protocols, exploring less toxic and more effective therapeutic strategies is of critical importance. …”
    Get full text
    Article
  15. 1355

    Fournier’s gangrene: the current state of the problem and our treatment experience by S. A. Aliev, E. S. Aliev

    Published 2022-11-01
    “…The OBJECTIVE of the study was to analyze the results of treatment of patients with lightning scrotal gangrene (Fournier’s gangrene).METHODS AND MATERIAL. The work is based on the analysis of the results of treatment of 31 patients with Fournier’s gangrene aged 32 to 82 years. …”
    Get full text
    Article
  16. 1356

    Non-immunogenic staphylokinase in the high-risk pulmonary embolism treatment with subdural hematoma by S. L. Konstantinov, Zh. Yu. Chefranova, G. I. Stryabkova, S. A. Pribylov, I. B. Kovalenko, E. V. Gavrilyuk, S. V. Ivanov, S. S. Markin

    Published 2025-08-01
    “…To evaluate the safety and efficacy of the non-immunogenic staphylokinase in a patient with a massive high-risk pulmonary embolism (PE) with subdural hematoma.Material and methods. Non-immunogenic staphylokinase (Fortelyzin®, LLC “SuperGene”, Russia) is an original thrombolytic drug with high fibrin selectivity and minimal risk of bleeding. …”
    Get full text
    Article
  17. 1357

    Diagnostic capabilities of instrumental methods for studying early cardiovascular adverse events in patients with lymphoproliferative disorders, quality and safety issues by G. R. Gimatdinova, O. E. Danilova, I. L. Davydkin, U. L. Dzhulakyan, E. V. Usenko

    Published 2024-03-01
    “…To study the possibilities of instrumental research methods in relation to the earliest detection of cardiovascular events in oncohematological patients receiving antitumor immunochemotherapy, as well as to deter­mine the requirements for documenting adverse events.Material and methods. For the study, 63 patients were prospectively selected with a diagnosis of indolent non-Hodgkin lymphoma, who were indicated for antitumor immunochemotherapy. …”
    Get full text
    Article
  18. 1358

    Risk factors for myocardial infarction during carotid endarterectomy in high-risk patients with coronary artery disease by A. N. Vachev, O. V. Tereshina, O. V. Dmitriev, Yu. S. Belkin, P. A. Lebedev

    Published 2023-01-01
    “…In high-risk patients with CAD, severe impairment of local LV contractility and global LV systolic dysfunction are the most significant risk factors for perioperative MI during CEA.…”
    Get full text
    Article
  19. 1359
  20. 1360

    Heart failure in cancer patients by A. F. Khalirakhmanov, A. Z. Sharafeev, G. D. Gatiyatullina, S. V. Zinchenko, R. F. Gaifullina, A. A. Rizvanov

    Published 2022-01-01
    “…The purpose of the study was to conduct a systematic review of data on the role of heart failure (HF) in the development of cancer, as well as to discuss problems dealing with diagnosis and treatment of heart failure in cancer patients. Material and methods. A literature search was conducted using the Cochrane library, elibrary, medline, and embase databases over the past 7 years. …”
    Get full text
    Article